Gabapentinoids may not lead to higher fracture risk
Older adults prescribed gabapentinoids may not experience increased long-term fracture risk during treatment, according to results published in The Lancet Healthy Longevity.
“We are not claiming that gabapentinoids are free from the risks,” Kenneth K. C. Man, PhD, CStat, FHEA, FRSM, FRSPH, the senior author of the study and a pharmacoepidemiologist and medical statistician at University College London, told Healio. “Even when [patients] started the treatment on gabapentinoids, it had a 30% higher [fracture] risk compared with nontreatment periods. The more crucial one is when coprescribed with